129 related articles for article (PubMed ID: 19052491)
41. Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid.
La Rosa GL; Lupo L; Giuffrida D; Gullo D; Vigneri R; Belfiore A
Ann Intern Med; 1995 Jan; 122(1):1-8. PubMed ID: 7985890
[TBL] [Abstract][Full Text] [Related]
42. [Suppressive hormone therapy for thyroid nodules. Prospective evaluation. Preliminary results].
Wémeau JL; Cousty C; Vlaeminck V
Ann Endocrinol (Paris); 2000 May; 61(2):119-24. PubMed ID: 10891662
[TBL] [Abstract][Full Text] [Related]
43. Treatment of benign cold thyroid nodules: a randomized clinical trial of percutaneous laser ablation versus levothyroxine therapy or follow-up.
Papini E; Guglielmi R; Bizzarri G; Graziano F; Bianchini A; Brufani C; Pacella S; Valle D; Pacella CM
Thyroid; 2007 Mar; 17(3):229-35. PubMed ID: 17381356
[TBL] [Abstract][Full Text] [Related]
44. Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study.
Gharib H; James EM; Charboneau JW; Naessens JM; Offord KP; Gorman CA
N Engl J Med; 1987 Jul; 317(2):70-5. PubMed ID: 3295553
[TBL] [Abstract][Full Text] [Related]
45. [Results of levothyroxine therapy in thyroid nodules].
Sakalauskiene E; Jankuviene D; Musneckiene J
Medicina (Kaunas); 2002; 38(7):712-9. PubMed ID: 12474656
[TBL] [Abstract][Full Text] [Related]
46. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group.
Wémeau JL; Caron P; Schvartz C; Schlienger JL; Orgiazzi J; Cousty C; Vlaeminck-Guillem V
J Clin Endocrinol Metab; 2002 Nov; 87(11):4928-34. PubMed ID: 12414852
[TBL] [Abstract][Full Text] [Related]
47. A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules.
Papini E; Bacci V; Panunzi C; Pacella CM; Fabbrini R; Bizzarri G; Petrucci L; Giammarco V; La Medica P; Masala M
Clin Endocrinol (Oxf); 1993 May; 38(5):507-13. PubMed ID: 8330445
[TBL] [Abstract][Full Text] [Related]
48. Thyroxine suppressive therapy in patients with nodular thyroid disease.
Gharib H; Mazzaferri EL
Ann Intern Med; 1998 Mar; 128(5):386-94. PubMed ID: 9490600
[TBL] [Abstract][Full Text] [Related]
49. [Calcium-phosphorus metabolism and bone metabolism in postmenopausal patients with the thyroid gland pathology].
Esedova AE; Gadzhieva MM; Ferzilaeva RA
Klin Lab Diagn; 2002 Mar; (3):13-6. PubMed ID: 11980136
[TBL] [Abstract][Full Text] [Related]
50. On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign solitary, solid or predominantly solid, thyroid nodules.
Celani MF; Mariani M; Mariani G
Acta Endocrinol (Copenh); 1990 Dec; 123(6):603-8. PubMed ID: 2284885
[TBL] [Abstract][Full Text] [Related]
51. [Hormonal suppressive therapy of thyroid nodules].
Latapie JL; Leprat F; N'Guyen D; Catargi B; Latapie MJ
Ann Endocrinol (Paris); 1997; 58(6):459-62. PubMed ID: 9686004
[TBL] [Abstract][Full Text] [Related]
52. Short term effects of levothyroxine treatment in thyroid multinodular disease.
Cesareo R; Iozzino M; Isgrò MA; Annunziata F; Di Stasio E
Endocr J; 2010; 57(9):803-9. PubMed ID: 20683172
[TBL] [Abstract][Full Text] [Related]
53. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses.
Zelmanovitz F; Genro S; Gross JL
J Clin Endocrinol Metab; 1998 Nov; 83(11):3881-5. PubMed ID: 9814462
[TBL] [Abstract][Full Text] [Related]
54. Bone mineral density and metabolism in levothyroxine-treated adolescent girls with euthyroid diffuse goiter.
Matusik P; Małecka-Tendera E; Franek E; Januszek-Trzciakowska A
Endokrynol Pol; 2010; 61(1):14-9. PubMed ID: 20205099
[TBL] [Abstract][Full Text] [Related]
55. Suppressive levothyroxine therapy has no significant influence on bone degradation in women with thyroid carcinoma: a comparison with other disorders affecting bone metabolism.
Mikosch P; Jauk B; Gallowitsch HJ; Pipam W; Kresnik E; Lind P
Thyroid; 2001 Mar; 11(3):257-63. PubMed ID: 11327617
[TBL] [Abstract][Full Text] [Related]
56. Treatment of a major depression episode suppresses markers of bone turnover in premenopausal women.
Aydin H; Mutlu N; Akbas NB
J Psychiatr Res; 2011 Oct; 45(10):1316-20. PubMed ID: 21531430
[TBL] [Abstract][Full Text] [Related]
57. Thyroid-hormone-suppressive therapy in benign thyroid nodules.
Helling TJ
Lancet; 2003 Mar; 361(9363):1137. PubMed ID: 12672348
[No Abstract] [Full Text] [Related]
58. Levothyroxine therapy in patients with thyroid disease.
Mandel SJ; Brent GA; Larsen PR
Ann Intern Med; 1993 Sep; 119(6):492-502. PubMed ID: 8357116
[TBL] [Abstract][Full Text] [Related]
59. [Thyroxine therapy in benign thyroid nodules].
Vulpoi C; Zbranca E; Mogoş V; Preda C; Găleşanu C; Ungureanu MC; Ciobanu DG; Brănişteanu DD
Rev Med Chir Soc Med Nat Iasi; 2001; 105(1):95-100. PubMed ID: 12092166
[TBL] [Abstract][Full Text] [Related]
60. Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy.
Puzziello A; Carrano M; Angrisani E; Marotta V; Faggiano A; Zeppa P; Vitale M
J Endocrinol Invest; 2014 Dec; 37(12):1181-6. PubMed ID: 25008459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
